Correction: Neurological manifestations of SARS-CoV-2 infection: protocol for a sub-analysis of the COVID-19 critical care consortium observational study - Summary - MDSpire

Correction: Neurological manifestations of SARS-CoV-2 infection: protocol for a sub-analysis of the COVID-19 critical care consortium observational study

  • By

  • Denise Battaglini

  • Lavienraj Premraj

  • Matthew Griffee

  • Samuel Huth

  • Jonathon Fanning

  • Glenn Whitman

  • Diego Bastos Porto

  • Rakesh Arora

  • Lucian Durham

  • Eric Gnall

  • Marcelo Amato

  • Virginie Williams

  • Alexandre Noel

  • Sabrina Araujo De Franca

  • Gordan Samoukovic

  • Bambang Pujo

  • David Kent

  • Eva Marwali

  • Abdulrahman Al-Fares

  • Stephanie-Susanne Stecher

  • Mauro Panigada

  • Marco Giani

  • Giuseppe Foti

  • Paolo Pelosi

  • Antonio Pesenti

  • Nicole Marie White

  • Gianluig Li Bassi

  • Jacky Suen

  • John F. Fraser

  • Chiara Robba

  • Sung-Min Cho

  • May 1, 2026

  • 0 min

Share

Objective:

To address and correct an error in the classification of the modified Rankin Scale (mRS) domains, which is critical for accurately assessing neurological manifestations associated with SARS-CoV-2 infection.

Key Findings:
  • An error was identified in the original Figure 1 regarding the mRS classification, which could mislead interpretations of neurological outcomes.
  • The figure has been corrected and replaced in the updated article, ensuring accurate data representation.
Interpretation:

The correction ensures an accurate representation of the mRS domains, which is crucial for understanding and interpreting neurological outcomes in COVID-19 patients.

Limitations:
  • The correction pertains only to the figure and does not address other potential inaccuracies in the study; future updates may be necessary to resolve these.
Conclusion:

The original article has been updated to reflect the corrected classification of mRS domains, thereby enhancing the reliability of the findings related to neurological effects of SARS-CoV-2 and supporting ongoing research.

Original Source(s)

Related Content